Open AccessAbstract 1160: The novel osimertinib resistant lung cancer mice model harboring EGFR mutations driven by the SP-C promoter
Author(s) -
Kadoaki Ohashi,
Hisao Higo,
Go Makimoto,
Kenichiro Kudo,
Kazuya Nishii,
Kiichiro Ninomiya,
Hiroe Kayatani,
Takashi Ninomiya,
Toshio Kubo,
Kammei Rai,
Eiki Ichihara,
Katsuyuki Hotta,
Masahiro Tabata,
Katsuyuki Kiura
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-1160
Subject(s) - osimertinib , t790m , gefitinib , lung cancer , medicine , adenocarcinoma , epidermal growth factor receptor , cancer research , cancer , lung , tyrosine kinase inhibitor , pathology , erlotinib